Julien Tizot

BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, UK. All business in the United States, including registration, liaising with regulatory authorities, sales and distribution is handled by our subsidiary BioSpeedia LLC. We also have our subsidiary in Switerland, BioSpeedia International. Forepont provides BioSpeedia access to its global healthcare network, strategic relationships, and access to leading hospitals. Forepont’s Head of Europe, Julien Tizot, is also an Executive Board Member at BioSpeedia.

BayBridgeDigital is a game changing new company that drives digital transformation to create new growth and business value faster. BayBridgeDigital connects organizations, brands, technology and people through design-driven transformation, creating amazing customer experiences and building digital products. We are specialized in Digital transformation leveraging Salesforce. BayBridgeDigital operates in America, Europe and Middle East.

BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, UK. All business in the United States, including registration, liaising with regulatory authorities, sales and distribution is handled by our subsidiary BioSpeedia LLC. We also have our subsidiary in Switerland, BioSpeedia International. Forepont provides BioSpeedia access to its global healthcare network, strategic relationships, and access to leading hospitals. Forepont’s Head of Europe, Julien Tizot, is also an Executive Board Member at BioSpeedia.

BayBridgeDigital is a game changing new company that drives digital transformation to create new growth and business value faster. BayBridgeDigital connects organizations, brands, technology and people through design-driven transformation, creating amazing customer experiences and building digital products. We are specialized in Digital transformation leveraging Salesforce. BayBridgeDigital operates in America, Europe and Middle East.

Investing in companies that, through science and technology, cultivate joy to improve the way we live.

Forepont Capital Partners is a Medtech and biotech focused venture capital firm which was founded in 2017, headquartered in New York with a presence in Europe. Our mission is to invest in biotech, medtech and digital-health start-ups in the US and Europe while providing scientific, technological financial and operational support. The fund has developed strong and tight partnerships with industry leaders (researchers, hospitals, academia, large pharmaceutical groups) who have vastly contributed to the performance of the existing portfolio, and that contributed to generating a proprietary deal flow.

Trajectoire Capital Group is an investment manager with expertise in options, volatility trading and risk management. The Pillars of Trajectoire Philosophy > Understanding risk and building an asymmetric return profile > Capturing market inefficiencies > Seeking repeatable and recurring returns > Providing complementary return profiles for investors > Validating empirical strategies quantitatively > Preserving investor's optimism by providing risk awareness and comfort Our core business is focused on capturing pricing inefficiencies through volatility and options trading: Trajectoire offers the following strategies: • Trajectoire Black Tail Strategy's objective is to offer a convex profile with alpha generating options arbitrages on listed futures. • Bespoke tail hedging solutions • Trajectoire Crypto Arbitrage Strategy, leveraging on our long standing expertise in options and volatility aiming at absolute positive returns independently of the direction on any cryptocurrency.